Core Viewpoint - A class action securities lawsuit has been filed against AstraZeneca PLC, alleging securities fraud that negatively impacted investors between February 23, 2022, and December 17, 2024 [1][2]. Group 1: Allegations and Legal Exposure - The lawsuit claims that AstraZeneca engaged in insurance fraud in China, leading to increased legal risks [2]. - The allegations include that the President of AstraZeneca China was detained by law enforcement, which heightened the company's legal exposure [2]. - It is asserted that AstraZeneca understated its legal risks, and the revelations could materially harm its business activities in China [2]. Group 2: Investor Participation and Compensation - Investors who suffered losses during the specified timeframe have until February 21, 2025, to request to be appointed as lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and participation does not require serving as a lead plaintiff [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].
Lost Money on AstraZeneca PLC(AZN)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky